IMPACT AND MANAGEMENT OF DRUG-DRUG INTERACTIONS BETWEEN APIXABAN OR RIVAROXABAN AND SYSTEMIC AZOLE ANTIFUNGAL THERAPY.

被引:0
作者
Stilwell, Allison [1 ]
Goldman, Svetlana [1 ]
Palkimas, Surabhi [1 ]
机构
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E61 / E61
页数:1
相关论文
共 50 条
  • [31] Real-life management of drug-drug interactions between antiretrovirals and statins
    Courlet, Perrine
    Livio, Francoise
    Saldanha, Susana Alves
    Scherrer, Alexandra
    Battegay, Manuel
    Cavassini, Matthias
    Stoeckle, Marcel
    Decosterd, Laurent Arthur
    Marzolini, Catia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1972 - 1980
  • [32] DRUG-DRUG INTERACTION DATABASES: SENSITIVITY AND SPECIFICITY TO DETECT MANIFEST DRUG-DRUG INTERACTIONS, RELIABILITY RATINGS AND MANAGEMENT STRATEGIES OF POTENTIAL DRUG-DRUG INTERACTIONS
    Ocovska, Z.
    Marikova, M.
    Kukralova, K.
    Vlcek, J.
    VALUE IN HEALTH, 2022, 25 (01) : S140 - S141
  • [33] Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions
    Lewis, Russell E.
    Andes, David R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (04) : 288 - 296
  • [34] Chiral Drug-Drug Interaction between Rivaroxaban Derivatives and Obstetrics Anaesthetic Drug Propofol
    Qi, Ting-Ting
    Yu, Zhou
    Wang, Hai-Rong
    Wang, Hai-Dong
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (07): : 1681 - 1685
  • [35] Molecular determinants on drug-drug interactions of systemic triazole antifungals
    Nivoix, Yasmine
    Leveque, Dominique
    Herbrecht, Raoul
    Koffel, Jean-Claude
    Beretz, Laurence
    Ubeaud-Sequier, Genevieve
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 117 - 118
  • [36] The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals
    Yasmine Nivoix
    Dominique Levêque
    Raoul Herbrecht
    Jean-Claude Koffel
    Laurence Beretz
    Genevieve Ubeaud-Sequier
    Clinical Pharmacokinetics, 2008, 47 : 779 - 792
  • [37] The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals
    Nivoix, Yasmine
    Leveque, Dominique
    Herbrecht, Raoul
    Koffel, Jean-Claude
    Beretz, Laurence
    Ubeaud-Sequier, Genevieve
    CLINICAL PHARMACOKINETICS, 2008, 47 (12) : 779 - 792
  • [38] ADME Pharmacogenetics and Its Impact on Drug-Drug Interactions
    Kerb, Reinhold
    Schwab, Matthias
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 51 - 74
  • [39] Drug-drug interactions in HIV therapy: is it all clear?
    Burger, David
    Back, David
    ANTIVIRAL THERAPY, 2013, 18 (05) : 649 - 650
  • [40] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Ruijuan Xu
    Weihong Ge
    Qing Jiang
    European Journal of Clinical Pharmacology, 2018, 74 : 755 - 765